-
Je něco špatně v tomto záznamu ?
Probing the early stages of tablet disintegration by stress relaxation measurement
J. Tomas, M. Schöngut, O. Dammer, J. Beránek, A. Zadražil, F. Štěpánek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- ibuprofen chemie MeSH
- koncentrace vodíkových iontů MeSH
- laktosa chemie MeSH
- mechanický stres MeSH
- pevnost v tahu MeSH
- pomocné látky chemie MeSH
- tablety chemie MeSH
- Publikační typ
- časopisecké články MeSH
Rapid tablet disintegration is a requirement for the efficient dissolution of the active pharmaceutical ingredient (API) from immediate release tablets. From the mechanistic viewpoint, tablet disintegration begins by the wetting of the tablet surface and the ingress of dissolution medium into the tablet pore structure, followed by the loosening of inter-particle bonds. The present work introduces a new methodology for probing and quantifying the early stages of tablet disintegration by stress relaxation measurements using texture analysis (TA). The method is based on applying a pre-defined load on the tablet by means of a needle-shaped probe and measuring the tablet resistance in time after the addition of the dissolution medium. This measurement provides information about the extent and rate of stress relaxation within the tablet upon hydration. Using a tablet formulation containing ibuprofen as the API and lactose as excipient, the effect of the API content, compaction pressure, and pH of the dissolution medium on the stress relaxation rate was systematically investigated. It is shown that using a dissolution medium pre-saturated by the formulation components has only a minor effect on the tablet disintegration rate compared to a pure phosphate buffer, meaning that the surface dissolution of particles within the tablet is not the main pre-requisite of disintegration in this case. On the other hand, pH of the dissolution medium was found to have a very strong effect on the stress relaxation rate in the tablet after wetting, suggesting that van der Waals interactions rather than solid bridges are the predominant particle bonding mechanism in the investigated formulations.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012432
- 003
- CZ-PrNML
- 005
- 20230703090517.0
- 007
- ta
- 008
- 190405s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2018.08.029 $2 doi
- 035 __
- $a (PubMed)30149061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Tomas, Jan $u Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 3, 166 28 Prague 6, Czech Republic; Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic.
- 245 10
- $a Probing the early stages of tablet disintegration by stress relaxation measurement / $c J. Tomas, M. Schöngut, O. Dammer, J. Beránek, A. Zadražil, F. Štěpánek,
- 520 9_
- $a Rapid tablet disintegration is a requirement for the efficient dissolution of the active pharmaceutical ingredient (API) from immediate release tablets. From the mechanistic viewpoint, tablet disintegration begins by the wetting of the tablet surface and the ingress of dissolution medium into the tablet pore structure, followed by the loosening of inter-particle bonds. The present work introduces a new methodology for probing and quantifying the early stages of tablet disintegration by stress relaxation measurements using texture analysis (TA). The method is based on applying a pre-defined load on the tablet by means of a needle-shaped probe and measuring the tablet resistance in time after the addition of the dissolution medium. This measurement provides information about the extent and rate of stress relaxation within the tablet upon hydration. Using a tablet formulation containing ibuprofen as the API and lactose as excipient, the effect of the API content, compaction pressure, and pH of the dissolution medium on the stress relaxation rate was systematically investigated. It is shown that using a dissolution medium pre-saturated by the formulation components has only a minor effect on the tablet disintegration rate compared to a pure phosphate buffer, meaning that the surface dissolution of particles within the tablet is not the main pre-requisite of disintegration in this case. On the other hand, pH of the dissolution medium was found to have a very strong effect on the stress relaxation rate in the tablet after wetting, suggesting that van der Waals interactions rather than solid bridges are the predominant particle bonding mechanism in the investigated formulations.
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a ibuprofen $x chemie $7 D007052
- 650 _2
- $a laktosa $x chemie $7 D007785
- 650 _2
- $a mechanický stres $7 D013314
- 650 _2
- $a tablety $x chemie $7 D013607
- 650 _2
- $a pevnost v tahu $7 D013718
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Schöngut, Marek $u Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic.
- 700 1_
- $a Dammer, Ondřej $u Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic. $7 xx0303489
- 700 1_
- $a Beránek, Josef $u Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic.
- 700 1_
- $a Zadražil, Aleš $u Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Štěpánek, František $u Department of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 3, 166 28 Prague 6, Czech Republic. Electronic address: Frantisek.Stepanek@vscht.cz.
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences $x 1879-0720 $g Roč. 124, č. - (2018), s. 145-152
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30149061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20230703090515 $b ABA008
- 999 __
- $a ok $b bmc $g 1391742 $s 1050737
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 124 $c - $d 145-152 $e 20180824 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20190405